Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy J Brown

Showing results (1-10 of 217) with videos related to

Pageof 22
Sort By:
Circulation|May 21, 2003
Eplerenone: cardiovascular protectionNancy J Brown
Journal of the American Society of Hypertension : JASH|March 22, 2012
Cardiovascular effects of antidiabetic agents: focus on blood pressure effects of incretin-based therapiesNancy J Brown
Hypertension (Dallas, Tex. : 1979)|March 8, 2006
Blood pressure reduction and tissue-type plasminogen activator releaseNancy J Brown
Clinical and Translational Science|April 18, 2012
Patient-oriented research in the era of personalized medicineNancy J Brown
Therapeutic Advances in Cardiovascular Disease|July 28, 2010
Therapeutic potential of plasminogen activator inhibitor-1 inhibitorsNancy J Brown
Circulation Research|October 26, 2018
Developing Physician-ScientistsNancy J Brown
Transactions of the American Clinical and Climatological Association|July 23, 2013
Developing physician-scientists: a perspectiveNancy J Brown
Nature Reviews. Nephrology|June 19, 2013
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosisNancy J Brown
Current Opinion in Nephrology and Hypertension|April 12, 2005
Aldosterone and end-organ damageNancy J Brown
Transactions of the American Clinical and Climatological Association|June 21, 2011
This is not Dr. Conn's aldosterone anymoreNancy J Brown
Pageof 22

Showing results (1-10 of 217) with videos related to

Sort By:
Pageof 22
Circulation|May 21, 2003
Eplerenone: cardiovascular protectionNancy J Brown
Journal of the American Society of Hypertension : JASH|March 22, 2012
Cardiovascular effects of antidiabetic agents: focus on blood pressure effects of incretin-based therapiesNancy J Brown
Hypertension (Dallas, Tex. : 1979)|March 8, 2006
Blood pressure reduction and tissue-type plasminogen activator releaseNancy J Brown
Clinical and Translational Science|April 18, 2012
Patient-oriented research in the era of personalized medicineNancy J Brown
Therapeutic Advances in Cardiovascular Disease|July 28, 2010
Therapeutic potential of plasminogen activator inhibitor-1 inhibitorsNancy J Brown
Circulation Research|October 26, 2018
Developing Physician-ScientistsNancy J Brown
Transactions of the American Clinical and Climatological Association|July 23, 2013
Developing physician-scientists: a perspectiveNancy J Brown
Nature Reviews. Nephrology|June 19, 2013
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosisNancy J Brown
Current Opinion in Nephrology and Hypertension|April 12, 2005
Aldosterone and end-organ damageNancy J Brown
Transactions of the American Clinical and Climatological Association|June 21, 2011
This is not Dr. Conn's aldosterone anymoreNancy J Brown
Pageof 22